federal judge invalidated seven patents involving the genes BRCA1 and BRCA2

Announcements
On Monday, March 29th, a U.S. federal judge invalidated seven patents involving the genes BRCA1 and BRCA2. Mutations of these genes have been linked to breast and ovarian cancer. The patents are held by Myriad Genetics and the University of Utah Research Foundation. Read news articles. Read the summary judgment. [PDF 859.20 KB]. 156 pages
http://www.genomicslawreport.com/wp-content/uploads/2010/03/Myriad-SJ-Opinion.pdf